# A Study to Compare PK, PD and Safety of CKD-381 and D026 in Healthy Subjects

> **NCT03558425** · PHASE1 · COMPLETED · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 41 (actual)

## Conditions studied

- GERD

## Interventions

- **DRUG:** CKD-381
- **DRUG:** D026

## Key facts

- **NCT ID:** NCT03558425
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-27
- **Primary completion:** 2018-09-14
- **Final completion:** 2018-09-14
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2018-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03558425

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03558425, "A Study to Compare PK, PD and Safety of CKD-381 and D026 in Healthy Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03558425. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*